Inhibition of skin protein kinase C by psychotropic drugs

Skin Pharmacology and Physiology

Volumn 10, Issue 4, 1997, Pages 191-199

  Vaitla, Rama ^a   Roshani, Pashootan ^a   Holian, Oksana ^b   Cook, Brian ^c   Kumar, Raj ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Jr Hospital of Cook County   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Endogenous and exogenous phosphorylation; Psychotropics; Skin PKC

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; DOXEPIN; FLUOXETINE; HYDROXYZINE; IMIPRAMINE; NEUROLEPTIC AGENT; PHOSPHOLIPID; PROTEIN; PROTEIN KINASE C; PSYCHOTROPIC AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; HYPNOTICS AND SEDATIVES; MICE; MICE, INBRED HRS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEINS; SKIN;

EID: 0030771003     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211504     Document Type: Article

References (38)

1. Rook A, Savin JA, Wilkinson DS: Psychocutaneous disorders; in Rook A, Savin JA, Wilkinson DS, ct al,(eds), Textbook of Dermatology, Oxford, Blackwell, 1986, pp 2257-2270.
2. Rostenbcrg A Jr: The role of psychogenic factors in skin diseases, Arch Dermatol 1960;81:81-83.
3. Gupta MA, Gupta AK, Haberman HF: Psychotropic drugs in dermatology, J Am Acad Dermatol 1986; 14:633-645.
4. Koblenzer CS: Pharmacology of psychotropic drugs useful in derma-tologic practice, Int J Dermatol 1993;32:162-168.
5. Koo JYM, Pham CT: Psychodcrma-tology for dermatologic patients, Dermatol Clin 1996;14:509-523.
6. Papahadjopoulos D: Studies on the mechanism of action of local anesthetics with phospholipid model membranes, Biochim Biophys Acta 1972;265:169-186.
7. Sceman P: The membrane actions of anesthetics and tranquilizers, Pharmacol Rev 1972;24:583-655.
8. Nishizuka Y: The family of protein kinase C for signal transduction, JAMA 1989;262:1826-1833.
9. Bell RM, Burns DJ: Lipid activation of protein kinase C, J Biol Chem 1991;266:4661-4664.
10. Mori T, Takai Y, Minakuchi R, Yu B, Nishizuka Y: Inhibitory' action of chlorpromazine, dibucainc and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase, J Biol Chem 1980;8378-8380.
11. Schatzman RC, Wise BC, Kuo JF: Phospholipid-sensitive calcium-dependent protein kinase: Inhibition by antipsychotic drugs, Biochem Biophys Res Commun 1981:98: 669-676.
12. Chauhan VPS, Brokerhoff H: Phe-nobarbital competes with diacylgly-cerol for protein kinase C, Life Sci 1987;40:89-93.
13. Mikawa K, Maekawa N, Hoshina H, Tanaka O, Shirakawa J, Goto R, Obara H, Kusunoki M: Inhibitory effect of barbiturates and local anesthetics on protein kinase activation, Int Med Res 1990;18:153-160.
14. Hcgcmann L, Fruchtmann R, Bon-nekoh B, Schmidt BH, Traber J, Mahrle G, Miller-Peddinghaus R, van Rooijen LAA: Effects of triflu-carbine as a dual protein kinase C/ calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes, Arch Dermatol Res 1991;283:456-460.
15. Hegemann L, Mahrle G: Mechanism of drug induced inhibition of kcratinocyte proliferation: Antagonism of calmodulin or inhibition of protein kinase C? Br J Dermatol 1993;129:644-645.
16. MacNeil S, Dawson RA, Crocker G, Tucker WFG, Bittiner B, Singleton JG, Hunter T, Tierney DF: Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity, BrJ Dermatol 1993;128:143-150.
17. Piozialeck WC, Weiss B: Inhibition of calmodulin by phenothiazines and related drugs: Structure-activity relationships, J Pharmacol Exp Ther 1982;222:509-516.
18. Koizumi H, Adachi K, Tsutsui M, Itami S, Katayama H, Halprin KM: Calcium-activated, phospholipid-dependent protein kinase in pig epidermis, J Invest Dermatol 1984,83: 261-264.
19. Koizumi H, Aoyagi T, Ohkawara A: Phosphorylation of soluble pig epidermal proteins by endogenous calcium-activated, phospholipid-dependent protein kinase, Arch Dermatol Res 1986;279:95-99.
20. Kumar R, Holian O: C-kinase phos-phorylates endogenous substrates from mouse skin, J Invest Dermatol 1987;88:501a.
21. Kumar R, Holian O, Fiedler VC: Interaction of phospholipids, retinoids and PMA with calcium, phospholipid-dependent protein kinase-catalyzed reaction in skin, Dermato-logica 1987; 175(suppl 1):56-66.
22. Kielbassa K, Muller JH, Meyer HE, Marks F, Gschwendt M: Protein kinase C delta-specific phosphorylation of the elongation factor eEF-alpha and an cEF-1 alpha peptide at threonine 431, J Biol Chem 1995; 270:6156-6162.
23. Nishikawa K, Yamamoto S, Otsuka C, Kato R: Characterization of endogenous substrates for novel-type protein kinase C as well as conventional-type protein kinase C in primary cultured mouse epidermal cells, Cell Signal 1992;6:757-776.
24. Nishikawa K, Yamamoto S, Nagu-mo H, Ishihara M, Murayama N, Kato R: KP-10, a novel protein kinase C substrate in intact mouse epidermal cells, is phosphorylated by novel protein kinase C eta and/or zeta, Cell Signal 1994;6:503-512.
25. Kumar R, Holian O: Inhibition of mouse skin protein kinase C by benzoyl peroxide, J Invest Dermatol 1991;96:490-494.
26. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with Folin phenol reagent, J Biol Chem 1951;193:265-275.
27. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 1970;227:680-685.
28. Kumar R, Holian O, Cook B, Ro-shani P: Inhibition of rat brain protein kinase C by lipid soluble psychotropics, Neurochem Res 1997; 22:1-10.
29. Bazzi M, Nelscstuen GL: Substrate specific stimulation of protein kinase C by polyvalent anions, Biochem Biophys Res Commun 1987; 147:248-253.
30. Sovignct C, Chambas EM: Phospholipid independent phosphorylation of proteins by protein kinase C: Effect of polyanions, Cell Signal 1990: 2:171-176.
31. Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics, ed 8, New York, McGraw Hill, 1990, pp 288-435.
32. Huang KP, Nakabayashi H, Huang FL: Isozymic forms of rat brain calcium-activated and phospholipid-dependent protein kinase, Proc Natl Acad Sci USA 1986;83:8535-8539.
33. Wang X-J, Warren BS, Beltran LM, Fosmire S, DiGiovanni J: Further identification of protein kinase C isozymes in mouse epidermis, J Cancer Res Clin Oncol 1993; 119: 279-287.
34. Chida K, Yamada S, Kato N, Kuroti T: Phosphorylation of Mr 34,000 and 40,000 proteins by protein kinase C in mouse epidermis in vitro, Cancer Res 1988;48:4018-4023.
35. Cimino M, Benfenati F, Farabegoli C, Cattabeni F, Fuxe K, Agnati LF, Toffano G: Differential effect of ganglioside GM1 on rat brain phos-phoproteins: Potentiation and inhibition of protein phosphorylation regulated by calcium/calmodulin and calcium/phospholipid-depen-dent protein kinases, Acta Physiol Scand 1987;130:317-325.
36. +Vcalmodulin-de-pendent and Ca**/phospholipid-de-pendcnt protein kinases in rat adrenal glomerulosa cells, J Steroid Biochem 1988;29:277-283.
37. +-dcpcndent protein kinase from bovine thyroid: Characterization and subcellular distribution of the enzyme and its substrates, Metabolism 1986;35:457-465.
38. Inohara S: Studies and perspectives of signal transduction in the skin, Exp Dermatol 1992;1:207-220.